scispace - formally typeset
D

Daniel Prieto-Alhambra

Researcher at University of Oxford

Publications -  438
Citations -  11189

Daniel Prieto-Alhambra is an academic researcher from University of Oxford. The author has contributed to research in topics: Population & Medicine. The author has an hindex of 45, co-authored 345 publications receiving 7269 citations. Previous affiliations of Daniel Prieto-Alhambra include Erasmus University Medical Center & Mount Vernon Hospital.

Papers
More filters
Journal ArticleDOI

Prevalence and predictors of vitamin D deficiency in non-supplemented women with systemic lupus erythematosus in the Mediterranean region: a cohort study

Juan Muñoz-Ortego, +4 more
- 17 Nov 2012 - 
TL;DR: Vitamin D insufficiency is highly prevalent among SLE patients, even in southern regions, andSunscreen use and obesity increase the risk.
Journal ArticleDOI

Hormone replacement therapy and mid-term implant survival following knee or hip arthroplasty for osteoarthritis: a population-based cohort study

Daniel Prieto-Alhambra, +5 more
- 01 Mar 2015 - 
TL;DR: HRT use is associated with an almost 40% reduction in revision rates after a TKA/THA, and preoperative HRT appeared unrelated to implant survival.
Journal ArticleDOI

Fractures in users of antidepressants and anxiolytics and sedatives: effects of age and dose.

Peter Vestergaard, +6 more
- 01 Feb 2013 - 
TL;DR: Increasing age was associated with more fractures in users of selective serotonin reuptake inhibitors and tricyclic antidepressants, whereas for anxiolytics and sedatives, more fractures were seen among the younger users, and a hospital diagnosis of depression or manic depression was not a risk factor for fractures.
Journal ArticleDOI

Vitamin D threshold to prevent aromatase inhibitor-related bone loss: the B-ABLE prospective cohort study

Daniel Prieto-Alhambra, +13 more
- 21 Mar 2012 - 
TL;DR: It is concluded that improved vitamin D status using supplementation is associated with attenuation of AI-associated bone loss and the current Institute of Medicine target recommendation of 20 ng/ml might be too low to ensure good bone health.
Journal ArticleDOI

Drug utilization in patients with OA: a population-based study

Nathan J. Wilson, +7 more
- 01 May 2015 - 
TL;DR: Drug combinations are common in the treatment of OA patients, who are thus exposed to potential drug interactions, with unknown impacts on their health, including the increasing use of opioids and COX-2 inhibitors.